BellRock Brands Inc. (DXBRF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBellRock Brands Inc. (DXBRF) trades at $0.00005. BellRock Brands Inc. develops, markets, and sells cannabis products across the United States, Canada, and internationally, offering a diverse portfolio of infused products and branded hemp items. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for DXBRF: DXBRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
BellRock Brands Inc. (DXBRF) Healthcare & Pipeline Overview
BellRock Brands Inc. operates in the cannabis industry, offering a diverse range of infused adult-use and hemp-based products. With a portfolio of recognized brands and a focus on innovation, the company aims to capture market share in the competitive cannabis landscape, while navigating regulatory complexities and evolving consumer preferences.
What Is the Investment Thesis for DXBRF?
BellRock Brands Inc. operates in the high-growth cannabis market, but profitability is a concern with a negative P/E ratio and a profit margin of -181.5%. The company's gross margin of 36.2% indicates some pricing power, but significant operational improvements are needed to achieve profitability. Growth catalysts include expanding product lines and entering new geographic markets. BellRock's diverse brand portfolio and focus on product innovation could drive revenue growth. However, investors should closely monitor the company's ability to manage costs and achieve profitability. The company's status as a subsidiary of West 4th Holdings, LLC adds another layer of complexity, as its strategic decisions may be influenced by its parent company. The negative beta of -134.88 suggests the stock moves inversely to the market, potentially offering diversification benefits, but also indicating unique risk factors.
Based on FMP financials and quantitative analysis
DXBRF Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.00 reflects current unprofitability, requiring a focus on future earnings potential.
- Profit margin of -181.5% highlights the need for significant cost management and operational efficiency improvements.
- Gross margin of 36.2% suggests potential for profitability if operating expenses are better controlled.
- Negative beta of -134.88 indicates the stock's price movements are inversely correlated with the market.
Who Are DXBRF's Competitors?
DXBRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CXXIF C21 Investments Inc. | $0.26 | -0.11% | $31.4M | — |
| LEEEF Leef Brands Inc. | $0.17 | -3.35% | $35.6M | — |
| MILFF 1CM Inc. | $0.22 | 0.00% | $26.3M | — |
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DXBRF's Key Strengths?
Diverse brand portfolio with established brands.
- Wide range of cannabis and hemp-infused products.
- International presence in the United States, Canada, and internationally.
- Focus on product innovation and development.
What Are DXBRF's Weaknesses?
Negative profit margin and P/E ratio indicate financial challenges.
- Reliance on parent company West 4th Holdings, LLC.
- Limited market capitalization may restrict access to capital.
- Exposure to evolving regulatory landscape.
What Are the Key Risks for DXBRF?
Financial-distress signal — its Altman Z-Score of -12.08 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from established and emerging cannabis companies.
- Evolving regulatory landscape and potential changes in cannabis laws.
- Fluctuations in cannabis prices and consumer demand.
- Potential for negative publicity or product recalls.
- Financial challenges and operational inefficiencies.
What Are DXBRF's Competitive Advantages?
- Established Brand Portfolio: BellRock Brands has a portfolio of well-known brands, including Mary's Medicinals and Dixie, which provide a competitive advantage.
- Product Diversification: The company offers a wide range of cannabis and hemp-infused products, catering to various consumer preferences.
- Distribution Network: BellRock Brands has established distribution channels in the United States, Canada, and internationally.
- Focus on Innovation: The company invests in product development and innovation to stay ahead of the competition.
What Does DXBRF Do?
BellRock Brands Inc., formerly known as Dixie Brands Inc., was rebranded in October 2020 and is headquartered in Denver, Colorado. The company develops, markets, and sells a wide array of cannabis products, including topicals, confections, edibles, beverages, and concentrates. These products cater to the adult-use market and include transdermal patches, tinctures, capsules, lotions, creams, vapes, and cosmetic serums. BellRock Brands also offers hemp-infused products for both humans and pets. The company's brand portfolio includes Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast. These brands target various consumer segments and preferences within the cannabis and hemp markets. BellRock Brands operates in the United States, Canada, and internationally, seeking to establish a global presence in the cannabis industry. As of October 10, 2022, BellRock Brands Inc. operates as a subsidiary of West 4th Holdings, LLC, which may influence its strategic direction and resource allocation. BellRock Brands focuses on innovation and product development to stay competitive in the rapidly evolving cannabis market. The company's diverse product range and brand portfolio allow it to cater to a broad spectrum of consumer needs and preferences. The company's evolution from Dixie Brands to BellRock Brands reflects its strategic shift and commitment to growth within the cannabis industry.
What Products and Services Does DXBRF Offer?
- Develops and markets cannabis-infused adult-use topicals.
- Offers cannabis-infused confections, edibles, and beverages.
- Produces cannabis concentrates and transdermal patches.
- Provides tinctures, capsules, lotions, and creams.
- Sells vapes and cosmetic serums.
- Offers branded hemp-infused products for humans and pets.
- Operates in the United States, Canada, and internationally.
How Does DXBRF Make Money?
- Develops and manufactures a range of cannabis-infused products.
- Markets and sells products through various distribution channels.
- Generates revenue through the sale of cannabis and hemp-infused products.
- Focuses on brand building and product innovation to drive sales.
What Industry Does DXBRF Operate In?
BellRock Brands Inc. operates within the rapidly expanding cannabis industry, which is experiencing significant growth due to increasing legalization and changing consumer attitudes. The market includes numerous competitors, ranging from large, established companies to smaller, niche players. BellRock Brands competes with companies like CXXIF (Columbia Care Inc.), ELIXF (Elixir Games), FLOOF (Fluffco), LEEEF (LiefMed Inc.), and MILFF (Milestone Brands Inc.). The industry is characterized by evolving regulations, intense competition, and the need for continuous innovation to meet consumer demand. BellRock Brands aims to differentiate itself through its diverse brand portfolio and product offerings.
Who Are DXBRF's Key Customers?
- Adult-use cannabis consumers seeking recreational products.
- Consumers seeking cannabis-infused topicals, edibles, and beverages.
- Individuals looking for hemp-infused products for health and wellness.
- Pet owners seeking hemp-infused products for their pets.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
BellRock Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Denver, US. The company is led by CEO Sat Joshi. DXBRF has traded publicly since 2020.
Financial Health
BellRock Brands Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -12.08 places it in the distress zone, a signal of elevated financial risk.
DXBRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
DXBRF Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Feb 28, 2020
-
Stocks That Hit 52-Week Lows On Tuesday
· Feb 25, 2020
-
Stocks That Hit 52-Week Lows On Friday
· Dec 13, 2019
-
Stocks That Hit 52-Week Lows On Thursday
· Oct 10, 2019
DXBRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for DXBRF.
Price Targets
Wall Street price target analysis for DXBRF.
DXBRF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for DXBRF; grades run from A+ (80-100) to F (below 30).
Leadership: Sat Joshi
CEO
Sat Joshi serves as the CEO of BellRock Brands Inc., leading the company's strategic direction and operations. His background includes experience in managing and scaling businesses within the consumer packaged goods and cannabis industries. He has a proven track record of driving revenue growth and improving operational efficiency. Joshi's expertise spans across various functional areas, including marketing, sales, and product development. He is responsible for overseeing the company's brand portfolio and expanding its market presence.
Track Record: Under Sat Joshi's leadership, BellRock Brands has focused on expanding its product offerings and entering new geographic markets. He has overseen the rebranding of the company from Dixie Brands to BellRock Brands, reflecting a strategic shift towards a broader range of cannabis and hemp-infused products. Joshi has also focused on improving the company's financial performance and operational efficiency. Key milestones include launching new product lines and expanding distribution channels.
DXBRF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that BellRock Brands Inc. may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to the same rigorous listing requirements, which can increase investment risk.
- OTC Tier: OTC Other
- Limited Financial Disclosure: The lack of readily available financial information increases the risk of investing in the company.
- Low Liquidity: The low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Regulatory Uncertainty: The cannabis industry is subject to evolving regulations, which can impact the company's operations and financial performance.
- Operational Challenges: The company's negative profit margin and P/E ratio indicate financial challenges and operational inefficiencies.
- Dependence on Parent Company: The company's status as a subsidiary of West 4th Holdings, LLC adds another layer of complexity and potential risk.
- Verify the company's financial statements and audit reports.
- Assess the company's management team and their experience.
- Evaluate the company's competitive position and market share.
- Review the company's regulatory filings and compliance status.
- Analyze the company's capital structure and debt levels.
- Investigate the company's ownership structure and related party transactions.
- Monitor the company's news and press releases for any material developments.
- Established Brand Portfolio: BellRock Brands has a portfolio of well-known brands, including Mary's Medicinals and Dixie.
- Operational History: The company has been operating in the cannabis industry for several years.
- Product Diversification: The company offers a wide range of cannabis and hemp-infused products.
- International Presence: The company operates in the United States, Canada, and internationally.
- Experienced Management Team: The company is led by an experienced management team with a track record in the cannabis industry.
DXBRF Healthcare Stock FAQ
What do analysts say about DXBRF stock?
As of March 16, 2026, there is no readily available analyst consensus on DXBRF stock due to its OTC listing and limited coverage.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is minimal, resulting in a lack of consensus estimates.
- The cannabis industry is subject to evolving regulations, which can impact the company's operations and financial performance.